Financial Network Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Financial Network Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43K	Buy	340 +12	+4%	+$1.58K	0.04%	298
2026 Q1	$45.7K	Hold	328	–	–	0.05%	288
2025 Q4	$40.3K	Sell	328 -36	-10%	-$4.38K	0.04%	296
2025 Q3	$40.4K	Hold	364	–	–	0.04%	293
2025 Q2	$40.4K	Hold	364	–	–	0.05%	287
2025 Q1	$40.8K	Buy	364 +307	+539%	+$31.7K	0.05%	270
2024 Q4	$5.26K	Sell	57 -1,386	-96%	-$125K	0.01%	351
2024 Q3	$121K	Buy	1,443 +27	+2%	+$2.06K	0.1%	169
2024 Q2	$97.6K	Buy	+1,416	New	+$94.5K	0.07%	220

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Network Wealth Advisors's GILD Position: Q2 2026 in Review

Financial Network Wealth Advisors increased its Gilead Sciences (GILD) stake by 3.7% in Q2 2026, buying an estimated $1.58K and bringing the position to 340 shares worth $43K. The position accounts for 0.04% of the portfolio, ranked #298.

Financial Network Wealth Advisors first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $121K in Q3 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Financial Network Wealth Advisors held 340 shares of Gilead Sciences worth $43K as of Q2 2026.
Financial Network Wealth Advisors bought 12 Gilead Sciences shares in Q2 2026, an estimated $1.58K.
Gilead Sciences made up 0.04% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #298 holding.
Financial Network Wealth Advisors first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
Financial Network Wealth Advisors's Gilead Sciences position peaked at $121K in Q3 2024.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.